Sowell Financial Services’s Actuate Therapeutics ACTU Stock Holding History

Sowell Financial Services’s Portfolio ACTU Stock Details ACTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.8K	Buy	+10,973	New	+$25.4K	﹤0.01%	1159

Other funds holding ACTU

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADEF

ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Sowell Financial Services's ACTU Position: Q2 2026 in Review

Sowell Financial Services opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 10,973 shares worth $16.8K. The stake represents ﹤0.01% of the portfolio and ranks #1159 among its holdings.

63 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

Sowell Financial Services held 10,973 shares of Actuate Therapeutics worth $16.8K as of Q2 2026.
Actuate Therapeutics was a new Sowell Financial Services position in Q2 2026.
Actuate Therapeutics made up ﹤0.01% of Sowell Financial Services's portfolio in Q2 2026, its #1159 holding.
63 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.